Keywords
- Gilteritinib fumarate
- ASP-2215 hemifumarate
Quick Details
- ProName: Gilteritinib hemifumarate
- CasNo: 1254053-84-3
- Molecular Formula: C29H44N8O3.1/2C4H4O4
- Appearance: White to yellow solid
- Application: For research use only.
- Purity: ≥95%
- Storage: Store at -20 °C
- LimitNum: 0
Superiority
We provide customized and high-quality Gilteritinib hemifumarate product for your project.
Details
Gilteritinib hemifumarate is a medication used to treat acute myeloid leukemia (AML), particularly in patients with specific genetic mutations in the FLT3 gene (FMS-like tyrosine kinase 3). Gilteritinib is a tyrosine kinase inhibitor that specifically targets and inhibits the FLT3 receptor, which is often mutated and overactive in certain types of AML. By inhibiting FLT3, gilteritinib helps to reduce the proliferation of leukemia cells.